Skip to main content

Peer Review reports

From: Quantitative benefit–harm assessment for setting research priorities: the example of roflumilast for patients with COPD

Original Submission
7 Nov 2014 Submitted Original manuscript
Author responded Author comments
Reviewed Reviewer Report
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
12 Jun 2015 Editorially accepted
2 Jul 2015 Article published 10.1186/s12916-015-0398-0

You can find further information about peer review here.

Back to article page